BLUEFIN BIOMEDICINE INC has a total of 28 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ISU ABXIS CO LTD, ALETA BIOTHERAPEUTICS INC and YAFEI SHANGHAI BIOLOG MEDICINE SCIENCE & TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 6 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | United States | 6 | |
#5 | China | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Tkachev Aleksandr | 19 |
#2 | Lonning Scott Michael | 19 |
#3 | Rikova Klarisa | 19 |
#4 | Pederson Nels Eric | 16 |
#5 | Beaudet Jason G | 12 |
#6 | Gu Tinglei | 12 |
#7 | Pederson Nels | 7 |
#8 | Lonning Scott | 7 |
#9 | Mulhern Daniel | 5 |
#10 | Ren Hong | 5 |
Publication | Filing date | Title |
---|---|---|
US2020308298A1 | Anti-ly6h antibodies and antibody drug conjugates | |
EP3638697A1 | Anti-il1rap antibodies and antibody drug conjugates | |
CA3064697A1 | Anti-vtcn1 antibodies and antibody drug conjugates | |
EP3601360A1 | Anti-tmeff1 antibodies and antibody drug conjugates | |
US2020031926A1 | Anti-ilt3 antibodies and antibody drug conjugates | |
CA3048224A1 | Anti-sez6l2 antibodies and antibody drug conjugates | |
WO2018112334A1 | Anti-cub domain-containing protein 1 (cdcp1) antibodies, antibody drug conjugates, and methods of use thereof | |
US2016145343A1 | Anti-mucin 1 binding agents and uses thereof |